GleamWall
中文EN

ADCT ADC Therapeutics SA

Pharmaceutical Preparations · NYSE · SEC CIK 1771910 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY12.8%
TTM net income YoY51.3%
TTM EPS YoY67.4%
Revenue 3-yr CAGR-11.5%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-97.7%
Net margin-95.7%
FCF margin-118.5%
EBITDA margin—

Returns

ROE—
ROA-29.8%
ROIC (approx.)—
Asset turnover0.31x

Leverage & solvency

Liabilities / assets197.4%
Debt / equity—
Current ratio3.05x
Interest coverage-1.58x

Cash quality & payout

Operating cash flow / net income1.24x
Accruals ratio7.1%
Payout ratio—
Capex / revenue0.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$81.36M$70.84M
Cost of revenue$5.80M$5.95M
Gross profit$75.56M$64.89M
R&D expense$104.00M$109.63M
SG&A expense$36.56M$41.89M
Operating income-$121.50M-$130.65M
Interest expense$51.63M$50.21M
Pretax income-$141.61M-$156.14M
Income tax$1.01M$166,000
Net income-$142.62M-$157.85M
EBITDA-$120.79M-$129.32M
EPS (basic)-1.12-1.62
EPS (diluted)-1.12-1.62
Weighted avg. shares (diluted)127.07M97.16M
Balance sheet
Cash & equivalents$261.34M$250.87M
Inventory$4.18M$2.25M
Current assets$306.33M$291.25M
PP&E, net$0$5.08M
Total assets$323.15M$321.98M
Current liabilities$70.16M$80.47M
Short-term debt$3.00M$0
Total liabilities$508.98M$524.62M
Shareholders' equity-$185.83M-$202.64M
Shares outstanding125.75M98.86M
Cash flow statement
Operating cash flow-$141.17M-$123.83M
Capital expenditure$264,000$867,000
Free cash flow-$141.44M-$124.70M
Investing cash flow$395,000-$867,000
Financing cash flow$150.94M$97.05M
Depreciation & amortization$705,000$1.33M
Stock-based compensation$6.91M$6.57M

Free plan shows the latest 2 periods; Pro shows all 8 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.